EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibition

Gemma A Wilson, Karla Vuina, Georgina Sava, Caroline Huard, Leticia Meneguello, Jasmin Coulombe-Huntington, Thierry Bertomeu, Rory J Maizels, Josh Lauring, Janos Kriston-Vizi, Mike Tyers, Simak Ali und 2 weitere

Molecular Cell · 2023

DOI: 10.1016/j.molcel.2023.10.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2023. Verfasst von Gemma A Wilson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Molecular Cell Biology, University College London, London, UK. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinases, Neoplasms. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent KinasesNeoplasmsHumansCyclin-Dependent Kinase-Activating KinaseSignal TransductionCell CycleEnzyme InhibitorsTOR Serine-Threonine KinasesCell Line, Tumor

Stichwörter der Autor:innen

CDK inhibitionCDK7 inhibitorcancer treatmentcell cyclecell sizecell-cycle arrestcellular growthmTOR singalingproliferationsamuraciclibsenescence

Substanzen

Cyclin-Dependent KinasesCyclin-Dependent Kinase-Activating KinaseEnzyme InhibitorsTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Laboratory for Molecular Cell Biology, University College London, London, UK.
  • Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK.
  • Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.
  • Laboratory for Molecular Cell Biology, University College London, London, UK; UCL Cancer Institute, University College London, London, UK.
  • Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada; Department of Bioengineering, McGill University, Montréal, QC, Canada.
  • Janssen Research and Development, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

Förderung

  • Cancer Research UK

Zitieren

APA

Wilson, G. A., Vuina, K., Sava, G., Huard, C., Meneguello, L., Coulombe-Huntington, J., Bertomeu, T., Maizels, R. J., Lauring, J., Kriston-Vizi, J., Tyers, M., Ali, S., Bertoli, C., & de Bruin, R. A. M. (2023). Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibition. Molecular Cell. https://doi.org/10.1016/j.molcel.2023.10.017

Vancouver

Wilson GA, Vuina K, Sava G, Huard C, Meneguello L, Coulombe-Huntington J, et al. Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibition. Molecular Cell. 2023. doi:10.1016/j.molcel.2023.10.017

BibTeX
@article{Wilson2023,
  author = {Wilson, Gemma A and Vuina, Karla and Sava, Georgina and Huard, Caroline and Meneguello, Leticia and Coulombe-Huntington, Jasmin and Bertomeu, Thierry and Maizels, Rory J and Lauring, Josh and Kriston-Vizi, Janos and Tyers, Mike and Ali, Simak and Bertoli, Cosetta and de Bruin, Robertus A M},
  title = {Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibition},
  journal = {Molecular Cell},
  year = {2023},
  doi = {10.1016/j.molcel.2023.10.017}
}
Kostenlos starten →